• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Dr Oz to face Senate grilling on Capitol Hill in bid to run Centers for Medicare and Medicaid

by March 14, 2025
written by March 14, 2025

Dr. Mehmet Oz, President Donald Trump’s pick to lead the Centers for Medicare and Medicaid, will face questions in front of the Senate Committee on Finance Friday morning. 

Following the hearing, the committee will schedule a vote to send Oz’s nomination to the full Senate, where approval is likely, considering the Republican majority.

If confirmed, Oz would be in charge of nearly $1.5 trillion in federal healthcare spending. Medicare, a federal healthcare program for seniors aged 65 and up, currently provides coverage for about 65 million Americans, according to the Center for Medicare Advocacy. Medicaid, which assists people with low incomes, covers roughly 72 million Americans, according to Medicaid.gov.

A former heart surgeon who saw his fame rise through his appearances on daytime TV and 13 seasons of ‘The Dr Oz Show,’ Oz later transitioned into politics, launching an unsuccessful bid for Pennsylvania’s open Senate seat in 2022. He ultimately lost to John Fetterman, then the state’s lieutenant governor. Oz graduated from Harvard and received medical and business degrees from the University of Pennsylvania. 

Oz is expected to be grilled by Democrats during the hearing over his financial ties to a myriad of healthcare-related companies, several of which pose potential conflicts of interest for the potential CMS director.

Oz has committed to divesting many of his financial interests that pose the most obvious risk of impropriety, such as his hundreds of thousands of dollars in stock in United Health Group, a major private health insurer. He also said that if he were confirmed, he would forfeit the nearly $25 million in stock options he obtained as an advisor to a company selling health and beauty supplements.

As the administrator of CMS, Oz would make decisions related to how the government covers procedures, hospital stays and medication within the federal healthcare programs, as well as the reimbursement rates at which healthcare providers get paid for their services. 

On Thursday, Trump’s pick to lead the NIH and FDA, Dr. Jay Bhattacharya and Dr. Marty Makary, respectively, were approved in committee and will now face impending votes by the full Senate.

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Dollar General CEO warns consumers are cash-strapped and says 2025 won’t be better
next post
Senate to take up Trump spending bill as clock ticks down to government shutdown

related articles

Vance visits church where Christians believe Jesus was...

October 23, 2025

New poll in key showdown for Virginia governor...

October 23, 2025

Americans could face airport chaos if Dems don’t...

October 23, 2025

Inside Trump’s ultimatum that forced Netanyahu to the...

October 23, 2025

Vance rebukes Israel on ‘very stupid’ vote to...

October 23, 2025

Top Republican slams Katherine Clark for admitting suffering...

October 23, 2025

Vance calls Psaki comments about wife Usha ‘disgraceful’

October 23, 2025

Trump yet to endorse in VA governor’s race...

October 23, 2025

DAVID MARCUS: Trump’s ballroom is no vanity project,...

October 23, 2025

Examining the next threat from Communist China: Our...

October 23, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Elon Musk outlines ‘super obvious’ changes DOGE and Treasury have agreed to make

    February 9, 2025
  • White House says Trump ‘trusts his physicians’ following Biden’s cancer announcement

    May 19, 2025
  • Haley urges her convention delegates to support Trump: ‘Republican unity’

    July 10, 2024
  • UN nuclear chief says Iran has material to build bombs, but no plan to do so

    June 20, 2025
  • FLASHBACK: Arizona Dem Senate candidate called Trump voters ‘dumb’: ‘Worst people in the world’

    September 28, 2024

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 3

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 4

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 5

    Biden calls to ‘lower the temperature’ then bashes Trump in NAACP speech

    July 17, 2024

Categories

  • Economy (829)
  • Editor's Pick (6,506)
  • Investing (634)
  • Stock (941)

Latest Posts

  • Don’t fall for fake settlement sites that steal your data

    October 13, 2025
  • White House slams Schumer’s ‘disgusting’ statement on shutdown as political standoff continues

    October 9, 2025
  • Radical new DOGE transparency powers could hit Congress after Elon Musk exit

    June 4, 2025

Recent Posts

  • Tim Walz and AOC play Madden on Twitch in attempt to appeal to young male voters

    October 28, 2024
  • Trump names Stefanik UN ambassador

    November 11, 2024
  • Microsoft ends use of China-based computer engineers for certain Defense Dept projects amid espionage fears

    July 19, 2025

Editor’s Pick

  • Donald Trump’s first vice president snags new job

    September 17, 2025
  • Trump strikes back with retaliatory measures against Colombia for rejecting deportation flights

    January 26, 2025
  • Tillis’ retirement announcement draws reactions from Trump critic Jeff Flake, Bernie Sanders: ‘A cult’

    June 29, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock